Clinical trials
Terminated Phase 1/2 Pancreatic Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
51 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 3 |
| 2008 | 1 |
| 2009 | 5 |
| 2010 | 1 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 5 |
| 2018 | 5 |
| 2019 | 4 |
| 2021 | 5 |
| 2022 | 5 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 51 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| ImmunityBio, Inc. | 4 |
| National Cancer Institute (NCI) | 4 |
| BioNTech SE | 2 |
| Massachusetts General Hospital | 2 |
| NantCell, Inc. | 2 |
| University of Texas Southwestern Medical Center | 2 |
| Washington University School of Medicine | 2 |
| Western Regional Medical Center | 2 |
| Alaunos Therapeutics | 1 |
| Ascentage Pharma Group Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pancreatic Neoplasms | 51 |
| Carcinoma, Non-Small-Cell Lung | 8 |
| Ovarian Neoplasms | 8 |
| Colorectal Neoplasms | 7 |
| Neoplasm Metastasis | 7 |
| Breast Neoplasms | 6 |
| Stomach Neoplasms | 5 |
| Carcinoma, Renal Cell | 3 |
| Cholangiocarcinoma | 3 |
| Esophageal Neoplasms | 3 |
Trials
Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.